STOCK TITAN

Silk Road Medical to Present at the Stifel 2021 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Silk Road Medical, a leader in stroke risk reduction technologies, will participate in the Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 1:20 p.m. ET. The event will feature a fireside chat showcasing the company’s pioneering TransCarotid Artery Revascularization (TCAR) procedure, which combines surgical principles and minimally invasive techniques to treat carotid artery disease. Interested parties can access the live and archived webcast via the company’s website.

For more information, visit www.silkroadmed.com.

Positive
  • None.
Negative
  • None.

SUNNYVALE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Stifel 2021 Virtual Healthcare Conference.

Silk Road Medical’s management is scheduled to present on Tuesday, November 16, 2021 at 1:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.   

About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.

Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com


FAQ

What is the date and time of Silk Road Medical's presentation at the Stifel 2021 Virtual Healthcare Conference?

Silk Road Medical will present on November 16, 2021, at 1:20 p.m. Eastern Time.

How can I access the webcast of Silk Road Medical's conference presentation?

The live and archived webcast can be accessed on the Investors section of Silk Road Medical's website.

What is the main focus of the Stifel 2021 Virtual Healthcare Conference for Silk Road Medical?

The conference will focus on Silk Road Medical's innovative approach to reducing stroke risk through its TCAR procedure.

What is TCAR and why is it significant in Silk Road Medical's operations?

TCAR, or TransCarotid Artery Revascularization, is a clinically proven procedure developed by Silk Road Medical to treat carotid artery disease, combining neuroprotection with minimally invasive techniques.

What is Silk Road Medical's stock symbol?

Silk Road Medical's stock symbol is SILK.

Silk Road Medical, Inc.

NASDAQ:SILK

SILK Rankings

SILK Latest News

SILK Stock Data

1.12B
40.63M
4.15%
97.46%
7.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SUNNYVALE